Kbc Group Nv Teva Pharmaceutical Industries LTD Transaction History

Kbc Group Nv

$37 Billion
Q2 2025

A detailed history of Kbc Group Nv transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Kbc Group Nv holds 55,414 shares of TEVA stock, worth $1.05 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

55,414

Previous 46,916 18.11%

Holding current value

$1.05 Million

Previous $721,000 28.85%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 08, 2025	BUY	$12.82 - $18.15 $108,944 - $154,238	8,498 Added 18.11%	55,414 $929,000
Q1 2025 Apr 25, 2025	BUY	$14.67 - $22.01 $143,076 - $214,663	9,753 Added 26.24%	46,916 $721,000
Q4 2024 Jan 22, 2025	BUY	$16.43 - $22.77 $184,344 - $255,479	11,220 Added 43.25%	37,163 $819,000
Q1 2024 May 08, 2024	BUY	$10.67 - $14.43 $114,521 - $154,877	10,733 Added 70.57%	25,943 $366,000
Q4 2023 Feb 13, 2024	SELL	$8.12 - $10.63 $50,067 - $65,544	-6,166 Reduced 28.85%	15,210 $159,000
Q2 2023 Feb 15, 2024	BUY	$7.2 - $9.47 $62,121 - $81,707	8,628 Added 67.68%	21,376 $161,000
Q2 2023 Jul 28, 2023	BUY	$7.2 - $9.47 $62,121 - $81,707	8,628 Added 67.68%	21,376 $0
Q3 2022 Feb 15, 2024	SELL	$6.86 - $11.95 $16,889 - $29,420	-2,462 Reduced 16.19%	12,748 $103,000
Q4 2021 Feb 14, 2024	SELL	$7.9 - $10.19 $19,449 - $25,087	-2,462 Reduced 16.19%	12,748 $102,000
Q4 2021 Feb 03, 2022	SELL	$7.9 - $10.19 $219,169 - $282,701	-27,743 Reduced 68.52%	12,748 $102,000
Q3 2021 Nov 10, 2021	BUY	$8.38 - $10.18 $117,395 - $142,611	14,009 Added 52.9%	40,491 $394,000
Q2 2020 Aug 10, 2020	SELL	$8.12 - $13.12 $173,954 - $281,069	-21,423 Reduced 44.72%	26,482 $327,000
Q1 2020 May 04, 2020	BUY	$6.69 - $13.45 $145,915 - $293,357	21,811 Added 83.59%	47,905 $430,000
Q2 2019 Jul 30, 2019	SELL	$8.12 - $15.72 $1.42 Million - $2.76 Million	-175,472 Reduced 87.05%	26,094 $0
Q1 2019 May 10, 2019	BUY	$15.58 - $20.01 $2.73 Million - $3.51 Million	175,472 Added 672.46%	201,566 $0
Q3 2018 Nov 14, 2018	SELL	$21.06 - $25.65 $315,900 - $384,750	-15,000 Reduced 36.5%	26,094 $0
Q2 2018 Aug 03, 2018	SELL	$16.77 - $24.71 $437,395 - $644,486	-26,082 Reduced 38.83%	41,094 $0
Q1 2018 May 09, 2018	BUY	$16.68 - $22.07 $405,524 - $536,565	24,312 Added 56.72%	67,176 $0
Q4 2017 Feb 07, 2018	SELL	$11.23 - $19.1 $73,264 - $124,608	-6,524 Reduced 13.21%	42,864 $0
Q3 2017 Nov 13, 2017	BUY	$15.41 - $32.17 $761,069 - $1.59 Million	49,388	49,388 $0

Others Institutions Holding TEVA

# of Institutions

658

Shares Held

659M

Call Options Held

30.1M

Put Options Held

16.4M

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $21.1B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.

Account